Apr
14
Boehringer Ingelheim reviews cough medicine in China
Posted in: UncategorizedSHANGHAI German pharmaceutical company Boehringer Ingelheim has called a creative review of its US$5 million Mucosolvan cough medicine brand in China, with four agencies, including incumbent Publicis and Y&R, believed to be competing for the account.
Post a Comment